Disability; Multiple sclerosis; Patient registry; Propensity score; Real-world date; Relapses; Treatment outcomes; Glatiramer Acetate; Humans; Immunologic Factors; Interferon-beta; Multiple Sclerosis, Relapsing-Remitting; Registries; Treatment Outcome; Neurology; Neurology (clinical)

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis / Kalincik, T., Jokubaitis, V., Izquierdo, G., Duquette, P., Girard, M., Grammond, P., Lugaresi, A., Oreja-Guevara, C., Bergamaschi, R., Hupperts, R., Grand'Maison, F., Pucci, E., Van Pesch, V., Boz, C., Iuliano, G., Fernandez-Bolanos, R., Flechter, S., Spitaleri, D., Cristiano, E., Verheul, F., et al.. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - STAMPA. - 21:(2015), pp. 1159-1171. [10.1177/1352458514559865]

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

AMATO, MARIA PIA;
2015

Abstract

Disability; Multiple sclerosis; Patient registry; Propensity score; Real-world date; Relapses; Treatment outcomes; Glatiramer Acetate; Humans; Immunologic Factors; Interferon-beta; Multiple Sclerosis, Relapsing-Remitting; Registries; Treatment Outcome; Neurology; Neurology (clinical)
2015
21
1159
1171
Kalincik, Tomas; Jokubaitis, Vilija; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Grammond, Pierre; Lugaresi, Alessandra; Oreja-Guevara, Celi...espandi
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1083795
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 34
social impact